These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Masters CL; Beyreuther K Brain; 2006 Nov; 129(Pt 11):2823-39. PubMed ID: 17012295 [TBL] [Abstract][Full Text] [Related]
3. Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease. Verhoeff NP Expert Rev Neurother; 2005 Mar; 5(2):277-84. PubMed ID: 15853497 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
5. [Fundamental data on the pathologies amyloid and Tau in Alzheimer's disease: which therapeutic perspectives?]. Checler F; Buée L Ann Pharm Fr; 2009 Mar; 67(2):136-53. PubMed ID: 19298897 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology. Silvestrelli G; Lanari A; Parnetti L; Tomassoni D; Amenta F Mech Ageing Dev; 2006 Feb; 127(2):148-57. PubMed ID: 16278007 [TBL] [Abstract][Full Text] [Related]
7. [Research progress on Alzheimer's disease: pathogenesis and medical therapy]. Sheng SL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):101-3. PubMed ID: 15171541 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies for Alzheimer's disease. Wolfe MS Nat Rev Drug Discov; 2002 Nov; 1(11):859-66. PubMed ID: 12415246 [TBL] [Abstract][Full Text] [Related]
10. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Pákáski M; Kálmán J Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955 [TBL] [Abstract][Full Text] [Related]
11. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793 [TBL] [Abstract][Full Text] [Related]
14. Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease. Bachurin SO Med Res Rev; 2003 Jan; 23(1):48-88. PubMed ID: 12424753 [TBL] [Abstract][Full Text] [Related]
15. [Alzheimer's disease: from brain lesions to new drugs]. Forette F; Hauw JJ Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689 [TBL] [Abstract][Full Text] [Related]
16. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques. Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic options in Alzheimer's disease. Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412 [TBL] [Abstract][Full Text] [Related]
18. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease. Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease: from pathology to therapeutic approaches. Jakob-Roetne R; Jacobsen H Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877 [TBL] [Abstract][Full Text] [Related]